Move the Needle : Episode 12

Podcast

Pharmacy Focus: Move the Needle Monday- Solving Common Vaccine Challenges with Motivational Interviewing

Motivational interviewing is a beneficial tool for health care providers to use for improving medication adherence, vaccine hesistancy, and more.

In this month's episode, John Beckner from NCPA speaks with Bruce Berger, PhD, FAPhA, President of Berger Consulting, LLC, about motivational interviewing in terms of solving common pharmacy issues, such as vaccine hesitancy and fatigue.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
American Captial Building.
Related Content
Doctor making a vaccination - Image credit: guerrieroale | stock.adobe.com
September 3rd 2025

New Clinical Guidance Recommends Vaccines to Protect Cardiovascular Patients From Respiratory Illness

Kennedy Ferruggia, Assistant Editor
Pharmacy Focus Oncology Edition Podcast
September 3rd 2025

Protecting Community Oncology Practices in the Wake of the IRA

Alexandra Gerlach, Associate Editor
rhinitis, medicine and healthcare concept - close up of sick woman using nasal spray | Image Credit: Syda Productions | stock.adobe.com
September 3rd 2025

FluMist Home Delivery Expands Access to Seasonal Influenza Vaccination

Danielle Valletti, Assistant Editor
From Guidelines to Action: Pharmacy’s Role in Hypertension Management
September 3rd 2025

From Guidelines to Action: Pharmacy’s Role in Hypertension Management

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
Blood sample tube for chikungunya test analysis. | Image Credit: kitsawet | stock.adobe.com
September 3rd 2025

FDA Suspends Licensing of Ixchiq Chikungunya Vaccine Amid Safety Concerns

Danielle Valletti, Assistant Editor
Man with shingles disease, skin infected with Herpes zoster, virus, Healthcare and medical - Image credit: Suriyawut | stock.adobe.com
September 3rd 2025

Dynavax’s Z-1018 Shingles Vaccine Candidate Shows Promising Immune Response and Safety in Early Trial

Kennedy Ferruggia, Assistant Editor